Atlas FDA

PBI

2 FDA 510(k) clearances · Product code

FDA profile

Official device name
Prosthesis, Hip, Constrained, Cemented Or Uncemented, Metal/Polymer, + Additive
Device class
Class II (moderate risk)
Regulation
21 CFR 888.3310
Medical specialty
Orthopedic
Flags
Implant
FDA definition
For use as a component of a total hip prosthesis in primary and revision patients at high risk of dislocation due to a history of prior dislocation, bone loss, joint or soft tissue laxity, neuromuscular disease, or intraoperative instability, and for whom all other options to constrained acetabular components have been considered.
Adverse events (MAUDE)
2021: 133 · 2022: 128 · 2023: 255 · 2024: 255 · 2025: 237 · 2026: 104
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
G7® Vivacit-E® Freedom® Constrained Liner (K212512)Zimmer, Inc.2022-04-28
G7 ACETABULAR SYSTEM (K121874)Biomet Manufacturing Corp2012-11-23

Track PBI automatically

Every clearance here is in the API, with alerts when new ones post.